69634 Federal Register / Vol. 88, No. 193 / Friday, October 6, 2023 / Notices 

Peggy Gartner, Deputy Office Head, U.S. 

National Science Foundation 

Alternate Members: None. 

Authority: 5 U.S.C. 4313(c)(4). 

Joshua Poole, 

Senior Management and Program Analyst, 

Federal Mine Safety and Health Review 

Commission. 

[FR Doc. 2023–22285 Filed 10–5–23; 8:45 am] 

BILLING CODE 6735–01–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (Act) (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12

CFR 225.41) to acquire shares of a bank

or bank holding company. The factors

that are considered in acting on the

applications are set forth in paragraph 7

of the Act (12 U.S.C. 1817(j)(7)).

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than October 23, 2023. 

A. Federal Reserve Bank of Dallas

(Karen Smith, Director, Mergers & 

Acquisitions) 2200 North Pearl Street, 

Dallas, Texas 75201–2272. Comments 

can also be sent electronically to 

Comments.applications@dal.frb.org: 

1. Wade O. Easley, individually and

as trustee of The La Plata Bancshares, 

Inc. Employee Stock Ownership Plan/ 

401K Trust (the ‘‘ESOP’’) and Holly W. 

Easley, all of Hereford, Texas; James O. 

Easley and Gloria Easley both of Wise 

River, Montana; and Steve Easley, 

Dawson, Texas; to become the Easley 

Family control group, a group acting in 

concert to retain voting shares of La 

Plata Bancshares, Inc., and thereby 

indirectly retain voting shares of The 

First National Bank of Hereford both of 

Hereford, Texas. Additionally, Wade O. 

Easley, individually and as trustee of 

the ESOP, to retain control of the voting 

shares of La Plata Bancshares, Inc., and 

indirectly voting shares of The First 

National Bank of Hereford. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–22310 Filed 10–5–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Council for the Elimination of 

Tuberculosis (ACET) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with regulatory 

provisions, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

Advisory Council for the Elimination of 

Tuberculosis Meeting (ACET). This 

meeting is open to the public, limited 

only by the number of audio and web 

conference lines (1,000 audio and web 

conference lines are available). Time 

will be available for the public. 

DATES: The meeting will be held on 

December 12, 2023, from 9:30 a.m. to 

4:30 p.m., EST, and December 13, 2023, 

from 10 a.m. to 12 p.m., EST. 

Written comments must be submitted 

by December 5, 2023. Registration to 

make oral comments must be submitted 

by December 5, 2023. 

ADDRESSES: The telephone access 

number is 1–669–254–5252, Webinar 

ID: Webinar ID: 160 466 2283, and the 

Passcode is 07266459. The web 

conference access is https://

cdc.zoomgov.com/j/1604662283?pwd=

czhoNzVrb1BYTHV0

bzc0R1hFSml0UT09 Passcode:

Xu0wFVH*. The number of available

audio and web conference lines is 1,000.

FOR FURTHER INFORMATION CONTACT:

Marah Condit, MS, Committee

Management Lead, Office of Policy,

Planning, and Partnerships, National

Center for HIV, Viral Hepatitis, STD,

and TB Prevention, Centers for Disease

Control and Prevention, 1600 Clifton

Road NE, Mailstop H24–6, Atlanta, GA

30329–4027, Telephone: (404) 639– 

3423; Email: nchhstppolicy@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Advisory Council for 

the Elimination of Tuberculosis (ACET) 

advises and makes recommendations 

regarding the elimination of 

tuberculosis (TB) to the Secretary of 

Health and Human Services, the 

Assistant Secretary for Health, and the 

Director, Centers for Disease Control 

and Prevention (CDC). Specifically, the 

Council makes recommendations 

regarding policies, strategies, objectives, 

and priorities; addresses the 

development and application of new 

technologies; provides guidance and 

review of CDC’s Tuberculosis 

Prevention Research portfolio and 

program priorities; and reviews the 

extent to which progress has been made 

toward eliminating TB. 

Matters to be Considered: The agenda 

will include discussions on: (1) data 

modernization initiative: DTBE 

priorities and activities; (2) NCHHSTP 

dataset and standardized variables; (3) 

TB Elimination Alliance: Community 

Engagement; and (4) updates from the 

American Thoracic Society; CDC; the 

Infectious Disease Society of America, 

and the European Respiratory Society 

on treatment guidelines. Agenda items 

are subject to change as priorities 

dictate. 

Public Participation 

Written Public Comment: Members of 

the public are welcome to submit 

written comments in advance of the 

meeting. Written comments must be 

submitted by emailing nchhstppolicy@

cdc.gov with the subject line ‘‘ACET

December 2023 Public Comment

Registration’’ by December 5, 2023.

Oral Public Comment: Individuals 

who would like to make an oral 

comment during the public comment 

period must register by emailing 

nchhstppolicy@cdc.gov with subject 

line ‘‘ACET December 2023 Public 

Comment Registration’’ by December 5, 

2023. The public comment period is on 

December 13, 2023, at 10:15 a.m., EST. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 


lotter on DSK11XQN23PROD with NOTICES1